African American patients are less likely than White patients to receive comprehensive pain treatment post- noncardiac ...

Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award winner for research showing how ...

The successful financings come amid a more than two-year stretch when the sector has struggled to attract fresh capital with ...

The following is a summary of “Preoperative Ketamine Gargle for Prevention of Postoperative Sore Throat After Tracheal ...

The following is a summary of “Utilizing Preoperative Rectus Sheath Blocks to Decrease Opioid Administration during Pediatric ...

Even liquid morphine couldn’t dull the agony. British television personality Richard Osman, 54, revealed he underwent emergency surgery at London’s Charing Cross Hospital after experiencing what he ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

Recommendations are presented to address infectious complications associated with regional anesthesia and pain management.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...